PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Hemic and Lymphatic Diseases, Hemorrhage, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Urogenital Diseases, Uterine Hemorrhage, cardiovascular disorder, diabetes mellitus, endocrine system disorder, fetal growth restriction, follicular lymphoma, gestational diabetes, glucose metabolism disease, hereditary endocrine growth disease, hypertension, pregnancy-induced, hypertensive disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, neoplasm, placenta disorder, placental abruption, preeclampsia, pregnancy disorder, puerperal disorder, vascular disorder	Recruiting	Not stated	2026-04-13		NCT07263490

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Copenhagen University Hospital, Hvidovre	34
Ferring Pharmaceuticals	18
Gedeon Richter Ltd.	3

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aleris Fertility	Søborg	Denmark	1
Copenhagen Fertility Center	Copenhagen	Denmark	1
Fertility Clinic, Herlev / Gentofte Hospital	Herlev	Denmark	1
Fertility Clinic, Rigshospitalet	København Ø	Denmark	1
Sellmer Klinik	København S	Denmark	1
Trianglen Fertility Clinic	Hellerup	Denmark	1